Predict your next investment

Virolock Technologies company logo
INDUSTRIAL | Manufacturing / Laboratory & Research Equipment Manufacturing
virolock.com

See what CB Insights has to offer

Stage

Grant - II | Alive

Total Raised

$80K

Last Raised

$80K | 4 yrs ago

About Virolock Technologies

Virolock Technologies has engineered a portable sample preparation platform that enables high‐efficiency virus enrichment from field samples (from cotton swabs and tissue biopsy), without using any antibody. The platform allows the specific capture of viral particles while removing host or sample contaminates. Viruses of interest are trapped by carefully tuning the filter pore size.

Virolock Technologies Headquarter Location

200 Innovation Blvd

State College, Pennsylvania, 16803,

United States

Latest Virolock Technologies News

Virolock seals $75,000 funding

May 4, 2017

4 May 2017 Virolock seals $75,000 funding Virolock Technologies was spun out of Penn State to commercialise a portable device that boosts early detection of viral infections. Author: Thierry Heles, editor Virolock Technologies, a medical device spinout of Pennsylvania State University (Penn State), has received $75,000 from the Fund for Innovation, an investment vehicle of Invent Penn State. Invent Penn State is a program launched by Penn State in 2015 to boost entrepreneurship across the US state of Pennsylvania. Virolock Technologies has developed portable technology that enables early virus detection and speeds up the identification of new viruses from field samples, where concentration can be low and make traditional technologies too expensive, slow or dependent on large-scale equipment. The technology was developed by Mauricio Terrones, professor of physics, chemistry and materials science in the Eberly College of Science with biomedical researchers Yin-Ting Yeh, Nestor Perea-Lopez and Si-Yang Zheng, associate professor in the College of Engineering. The money will support the setting up of lab space. Virolock will also use the cash to refine the manufacturing process of its disposable cartridges. The company previously obtained a $10,000 award following a participation in the Techcelerator @ State College accelerator, supported by Invent Penn State. Terrones said: “The device allows us to selectively trap and concentrate viruses by their size – smaller than human cells and bacteria, but larger than most proteins and other macromolecules – in incredibly dilute samples. “It further increases our ability to detect small amounts of a virus by more than 600 times." He added: “This could have major impacts on the way we detect and manage viral outbreaks across the globe. The technology could help medical personnel to develop vaccines in a more timely way, and lead to saving countless lives. “We are excited to bring this technology forward, and to take the next step with Virolock.” Copyright Mawsonia Limited 2010. Please don´t cut articles from www.globaluniversityventuring.com or the PDF and redistribute by email or post to the web without written permission.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.